• Synaptic dysfunction in migraine: novel approaches for drug development [abstract] 

    Kaja, S.; Hansen, K. S.; Mezeyova, J.; Qiu, L.; Gopaul, R. S.; Parker, D.; Snutch, T. P.; Nielsen, E. Ø.; Rønn, L. C. B.; Koulen, Peter (2010-03-06)
    Migraine is a severe paroxysmal neurovascular disorder, affecting up to 16% of the Western population. Current migraine drugs are largely targeted towards the pain associated with the migraine headache, and their efficacy ...